Pyridoxatin, an inhibitor of gelatinase A with cytotoxic activity

Journal of Microbiology and Biotechnology

Volumn 6, Issue 6, 1996, Pages 445-450

  Lee, Ho Jae ^a   Chung, Myung Chul ^a   Lee, Choong Hwan ^a   Chun, Hyo Kon ^a   Kim, Hwan Mook ^a   Kho, Yung Hee ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Chaunopycnis alha PT 262; DNA synthesis inhibitor; Gelatinase A inhibitor, cytotoxicity; Pyridoxatin

Indexed keywords

EID: 0003884364     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bihovsky, R., B. L. Levinson, R. C. Loewi, P. W. Erhardt, and M. A. Polokoff. 1995. Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle. J. Med. Chem. 38: 2199-2129.
2. Chitambar, C. R. and J. P. Wereley. 1995. Effect of hydroxyurea on cellular iron metabolism human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis. Cancer Res. 55: 4361-4366.
3. Davies, B., P. D. Brown, N. East, M. J. Crimmin, and F. R. Balkwill. 1993. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53: 2087-2091.
4. Elford, H. 1968. Effect of hydroxyurea on ribonucleotide reducatase. Biochem. Biophys. Res. Commun. 33: 129-135.
5. Elford, H. L., G. L. Wampler, and B. V. Riet. 1979. New ribonucleotide reductase inhibitors with antineoplastic activity. Cancer Res. 39: 844-851.
6. Gams, W. 1980. Chaunopycnis alba, gen. et. sp. nov., a soil fungus intermediate between moniliales and sphaeropsidales. Persoonia. 11: 75-79.
7. Gordon, J. J., B. K. Kelly, and M. A. Miller. 1962. Actinonin: an antibiotic substance produced by an actinomycete. Nature 195: 701-702.
8. Knight, C. G., F. Willenbrock, and G. Murphy. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296: 263-266.
9. Lee, H. J., M. C. Chung, C. H. Lee, H. K. Chun, and Y. H. Kho. 1995. Purification of progelatinase A (matrix metalloproteinase 2) and a tissue inhibitor of metalloproteinase-2 (TIMP-2) from T98G human glioblastoma cells. J. Biochem. Mol. Biol. 28: 33-39.
10. Neilands, J. B. 1967. Hydroxamic acids in nature. Science 156: 1443-1447.
11. Porter, J. R., N. R. A. Beeley, B. A. Boyce, B. Mason, A. Millican, K. Millar, J. Leonard, J. R. Morphy, and J. P. O'Connel. 1994. Potent and selective inhibitors of gelatinase A. 1. Hydroxamic acid derivatives. Bioorg. Med. Chem. Lett. 4: 2741-2746.
12. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. Mcmahon, D. Vostica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82: 1107-1112.
13. Stetler-Stevenson, W. G., S. Aznavoorian, and L. A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol. 9: 541-573.
14. Suda, H., T. Aoyagi, T. Takeuchi, H. Umezawa.1973. A thermolysin inhibitor produced by actinomycetes: phosphoramidon. J. Antibiot. 26: 621-623.
15. Tanzawa, K., M. Ishii, T. Ogita, and K. Shimada. 1992. Matlystatins, new inhibitors of typeIV collagenases from Actinomadura altramentoria. II. Biological activities. J. Antibiot. 45: 1733-1737.
16. Teshima, Y., K. Shin-ya, A. Shimazu, K. Furihata, S. C. Ha, K. Furihata, Y. Hayakawa, K. Nagai, and H. Seto. 1991. Isolation and structural elucidation of pyridoxatin, a free radical scavenger of microbial origin. J. Antibiot. 44: 685-687.
17. Umezawa, H., T. Aoyagi, T. Yanaka, H. Suda, A. Okuyama, H. Naganawa, M. Hamada, and T. Takeuchi. 1985. Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes. J. Antibiot. 38: 1629-1630.
18. Woessner, L F. Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.